Hepion Pharmaceuticals acquires Gravitas Life Sciences, installs new CEO
Hepion closed a deal for Gravitas Life Sciences on October 6, 2026, and named Sireesh Appajosyula as CEO three days later.
SEC filing
1 story
Hepion closed a deal for Gravitas Life Sciences on October 6, 2026, and named Sireesh Appajosyula as CEO three days later.
SEC filing